Sensorion Presents Initial Results of Phase 1b Clinical Study on SENS-111 at the AAO-HNSF Annual Meeting in San Diego

Read

Sensorion Presents Results of 2 Preclinical Trials at the 2016 IEB congress

Read

Sensorion Announces Positive Results From SENS-218 Phase 1 Clinical Trial Undertaken in the UK

Read

Sensorion Obtains FDA Approval to Initiate a Clinical Study of SENS-111 in Acute Severe Vertigo

Read

Sensorion strengthens its financial structure with the exercise of the second tranche of its financing agreement

Read

Next events